您的位置: 首页 > 2017年3月 第48卷 第2期 > 文字全文
2023年7月 第38卷 第7期11
目录

醒脑静联合连续肾脏替代疗法对脓毒症相关性脑病的疗效评价

Evaluation of curative effect of Xingnaojing combined with continuous renal replacement therapy on sepsis associated encephalopathy

来源期刊: 广州医药 | 40-42 发布时间:2021-12-01 收稿时间:2025/11/13 17:13:51 阅读量:33
作者:
关键词:
醒脑静连续肾脏替代疗法脓毒症疗效
Xingnaojing injectionContinuous renal replacement therapySepsisCurative effect
DOI:
10.3969/j.issn.1000-8535.2017.02.011
收稿时间:
2016-10-31 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨醒脑静联合连续肾脏替代疗法对脓毒症相关性脑病的疗效。方法 选取我院2014年6月—2016年6月收治的76例脓毒症相关性脑病患者作为研究对象,按照随机数字表法将其分成两组,每组38例。观察组给予醒脑静联合连续肾脏替代疗法治疗,对照组给予连续肾脏替代疗法治疗,比较两组患者的临床疗效,治疗前后格拉斯哥昏迷(Glasgow coma scale,GCS)评分、神经元特异性烯醇化酶(neuron-specifie enolase,NSE)含量、C-反应蛋白(C-reactive protein,CRP)含量及治疗后退热时间、恢复意识时间的长短。结果 观察组总有效率为89.47%,相对于对照组明显上升(P<0.05);观察组治疗后GCS评分较对照组明显升高,NSE含量、CRP含量较对照组明显降低,差异均有统计学意义(P<0.01);观察组治疗后的退热时间、恢复意识时间较对照组明显降低(P<0.01)。结论 醒脑静联合连续肾脏替代疗法对脓毒症相关性脑病的疗效显著,可有效缩短退热及恢复意识时间,降低患者痛苦,值得临床推广应用。
Objective To investigate the curative effect of Xingnaojing combined with continuous renal replacement therapy on sepsis associated encephalopathy. Methods 76 cases of sepsis associated encephalopathy in our hospital from June 2014 to June 2016 were selected as the research objects, and they were divided into two groups according to the random number table method, 38 cases in each group. The observation group were treated with Xingnaojing combined with continuous renal replacement therapy. The control group was given continuous renal replacement therapy. The clinical efficacy of two groups were compared before and after treatment about the Glasgow coma (Glasgow coma scale, GCS) score, neuron specific enolase (neuron-specifie enolase, NSE) content, C- reactive protein (C-reactive protein, CRP)content, and the length of the consciousness recovery time and pyretolysis time. Results In the observation group, the total effective rate was 89.47%. Compared with the control group. it increased significantly (P<0.05); After treatment the GCS score in the observation group was significantly higher than the control group, the content of NSE and CRP were significantly lower than the control group, the differences were statistically significant (P<0.01); In the observation group, after treatment the pyretolysis time, consciousness recovery time was significantly lower than the control group(P<0.01). Conclusion The curative effect of Xingnaojing combined with continuous renal replacement therapy on sepsis associated encephalopathy is significant and may effectively shorten the pyretolysis and the recovery of consciousness time, which is worthy of clinical application.
1、 吕苏,李佳,曹宝平,等.醒脑静注射液治疗脓毒症相关脑病的临床观察[J]. 中国中西医结合杂志,2015,35(7):792-795. 吕苏,李佳,曹宝平,等.醒脑静注射液治疗脓毒症相关脑病的临床观察[J]. 中国中西医结合杂志,2015,35(7):792-795.
2、 戴喜明,高青豹,胡清甫,等.醒脑净注射液联合床高流量持续血液净化治疗脓毒性休克48例临床分析[J]. 重庆医学,2016,45(14):1978-1980. 戴喜明,高青豹,胡清甫,等.醒脑净注射液联合床高流量持续血液净化治疗脓毒性休克48例临床分析[J]. 重庆医学,2016,45(14):1978-1980.
3、 梁道业,谢娟娟,林正佳,等.醒脑静联合连续肾脏替代治疗脓毒症脑病的临床观察[J]. 世界中西医结合杂志,2016,11(2):214-216. 梁道业,谢娟娟,林正佳,等.醒脑静联合连续肾脏替代治疗脓毒症脑病的临床观察[J]. 世界中西医结合杂志,2016,11(2):214-216.
4、 郭阳,左巍,曹莉,等.腹膜透析联合醒脑静注射液治疗尿毒症脑病临床观察[J]. 临床中医杂志,2015,43(12):1223-1225. 郭阳,左巍,曹莉,等.腹膜透析联合醒脑静注射液治疗尿毒症脑病临床观察[J]. 临床中医杂志,2015,43(12):1223-1225.
5、 杨国军,邵绍鳗,曹敏,等.醒脑静治疗脓毒症脑病的疗效观察[J]. 辽宁中医杂志,2015,42(7):1265-1267. 杨国军,邵绍鳗,曹敏,等.醒脑静治疗脓毒症脑病的疗效观察[J]. 辽宁中医杂志,2015,42(7):1265-1267.
6、 孙杰,张小坤,付素珍,等.持续性肾脏替代疗法联合血必净对脓毒症患者炎症反应水平、免疫状态及疾病严重程度的影响[J]. 广东医学,2015,28(3):387-391. 孙杰,张小坤,付素珍,等.持续性肾脏替代疗法联合血必净对脓毒症患者炎症反应水平、免疫状态及疾病严重程度的影响[J]. 广东医学,2015,28(3):387-391.
7、 赵敏.醒脑静注射液治疗脓毒症脑病的临床观察[J]. 陕西中医,2016,37(8):1007-1008. 赵敏.醒脑静注射液治疗脓毒症脑病的临床观察[J]. 陕西中医,2016,37(8):1007-1008.
8、 梅海峰,梁宗敏,叶纪录,等.连续肾脏替代疗法联合常规方案治疗脓毒症的效果分析[J]. 中国全科医学,2015,18(14):1711-1713. 梅海峰,梁宗敏,叶纪录,等.连续肾脏替代疗法联合常规方案治疗脓毒症的效果分析[J]. 中国全科医学,2015,18(14):1711-1713.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录